Literature DB >> 32803427

Laparoscopic-assisted anorectoplasty for intermediate type rectovestibular fistula: a preliminary report.

Long Li1, Xianghai Ren2,3,4, Anxiao Ming2, Yan Zhou2,3, Hang Xu2,3, Xuelai Liu2, Qi Li2, Xianghui Xie5, Mei Diao6.   

Abstract

PURPOSE: Laparoscopic-assisted anorectoplasty (LAARP) is considered to benefit the male patients with anorectal malformation (ARM). This study evaluates LAARP management for intermediate type rectovestibular fistula (IRVF) in the female patient with ARM.
METHODS: Twelve patients with IRVF (aged 3-5 months) underwent LAARP from 2017 to 2019 in our institute. LAARP was performed for mobilization of the rectum, visualization and enlargement of the center of the sphincter muscle complex (SMC) from pelvic and perineal aspects, intra-fistula mucosectomy and rectal pull-through in the SMC with the fourchette and the perineal body unattached.
RESULTS: LARRP was performed in all patients without conversion to open procedure. No patient suffered from wound infection, vaginal injury, recurrent fistula and anal stenosis. The parents were satisfied with the appearance of the wound. Rectal prolapse developed in one patient and needed surgical correction. The patients were followed up for a mean of 19.7 months (ranged from 12 to 35 months).
CONCLUSION: Our preliminary experience shows that LAARP offers an alternative method of correction for the IRVF with good visualization of the SMC and may diminish the risks of wound dehiscence and vaginal injury.

Entities:  

Keywords:  Anorectal malformation; Anorectoplasty; Laparoscopic; Vestibular fistula

Mesh:

Year:  2020        PMID: 32803427     DOI: 10.1007/s00383-020-04730-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  1 in total

1.  Refinements in surgical techniques for visualized tunnel formation in laparoscopic-assisted anorectoplasty.

Authors:  Long Li; Anxiao Ming; Yan Zhou; Hang Xu; Hailin Sun; Qi Li; Xu Li; Zhen Zhang; Mei Diao; Xianghui Xie
Journal:  Pediatr Surg Int       Date:  2021-04-26       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.